National Health Investors Inc (NHI) is now in the Fair zone, suggesting that its current forward PE ratio of 23.07 is considered Fairly compared with the five-year average of 21.04. The fair price of National Health Investors Inc (NHI) is between 83.49 to 102.44 according to relative valuation method.

Relative Value

Fair Zone

83.49-102.44

Current Price：87.58

Fair

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is National Health Investors Inc (NHI) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

National Health Investors Inc (NHI) has a current Price-to-Book (P/B) ratio of 2.47. Compared to its 3-year average P/B ratio of 2.23, the current P/B ratio is approximately 10.94% higher. Relative to its 5-year average P/B ratio of 2.08, the current P/B ratio is about 19.04% higher. National Health Investors Inc (NHI) has a Forward Free Cash Flow (FCF) yield of approximately 6.07%. Compared to its 3-year average FCF yield of 6.71%, the current FCF yield is approximately -9.52% lower. Relative to its 5-year average FCF yield of 7.11%, the current FCF yield is about -14.60% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for NHI competitors is 6.84, providing a benchmark for relative valuation. National Health Investors Inc Corp (NHI.N) exhibits a P/S ratio of 9.45, which is 38.14% above the industry average. Given its robust revenue growth of 23.40%, this premium appears sustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of NHI increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of NHI in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is NHI currently overvalued or undervalued?

What is National Health Investors Inc (NHI) fair value?

NHI's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of National Health Investors Inc (NHI) is between 83.49 to 102.44 according to relative valuation method.

How does NHI's valuation metrics compare to the industry average?

The average P/S ratio for NHI's competitors is 6.84, providing a benchmark for relative valuation. National Health Investors Inc Corp (NHI) exhibits a P/S ratio of 9.45, which is 38.14% above the industry average. Given its robust revenue growth of 23.40%, this premium appears sustainable.

What is the current P/B ratio for National Health Investors Inc (NHI) as of Mar 03 2026?

As of Mar 03 2026, National Health Investors Inc (NHI) has a P/B ratio of 2.47. This indicates that the market values NHI at 2.47 times its book value.

What is the current FCF Yield for National Health Investors Inc (NHI) as of Mar 03 2026?

As of Mar 03 2026, National Health Investors Inc (NHI) has a FCF Yield of 6.07%. This means that for every dollar of National Health Investors Inc's market capitalization, the company generates 6.07 cents in free cash flow.

What is the current Forward P/E ratio for National Health Investors Inc (NHI) as of Mar 03 2026?

As of Mar 03 2026, National Health Investors Inc (NHI) has a Forward P/E ratio of 23.07. This means the market is willing to pay $23.07 for every dollar of National Health Investors Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for National Health Investors Inc (NHI) as of Mar 03 2026?

As of Mar 03 2026, National Health Investors Inc (NHI) has a Forward P/S ratio of 9.45. This means the market is valuing NHI at $9.45 for every dollar of expected revenue over the next 12 months.

NHI Valuation